EGFR and lung adenocarcinoma: Clinical support and evidence to guide management are absent for NSCLC patients harboring EGFR fusion.<h4>Case presentation</h4>In this case report, we describe a 69-year-old female who received right lobectomy and was diagnosed with pathological stage IIIA lung adenocarcinoma harboring EGFR L858R.